Tag: Pharma
Intas launches HETRONIFLY, India’s first immunotherapy for advanced small cell lung...
Serplulimab is the first PD-1 inhibitor worldwide to receive approval for ES-SCLC, and is currently present in over 40 countries
India’s pharma exports surpass USD 30 Billion in FY2025 and aim...
The Rubix report further points to a clear shift in strategic priorities among Indian pharma firms, particularly as global risks mount
Sun Pharma’s phase 3 trials of ILUMYA support potential U.S. submission...
Both pivotal studies met their primary endpoint with statistically significant improvements based on ACR20 response rates at Week 24 with tildrakizumab 100 mg (ILUMYA) compared to placebo
Emcure Pharma, Sanofi India ink exclusive pact to expand reach of...
While Sanofi will continue to own and manufacture these brands across its plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
India’s pharma exports surge to US$ 4.96 Bn in April–May FY26:...
Enhance strategies to drive sustainability, global reach and digital transformation for a trillion-dollar future
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion...
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, licensing agreements for innovator oligonucleotides targeting CNS indications secured a cumulative total deal value of $6.05 billion from 2021 to 2025 YTD
UK biopharma venture financing QoQ doubles to $1.1 billion in Q1...
This surge highlights investor appetite for breakthrough innovation, but growing dependence on US capital and policy-driven cost pressures signal an urgent need to strengthen domestic investment
Biocon gets six-month extension on insulin supply pact in Malaysia
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Sun Pharma completes its acquisition of Checkpoint Therapeutics
As part of the acquisition, Sun Pharma acquires UNLOXCYTTM, the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma
Aurigene’s Dr. Gayathri Ramaswamy showcases exciting data on rapid design &...
Dr Ramaswamy's presentation highlighted the potential of these molecules to accelerate drug discovery by enabling targeted protein degradation with enhanced specificity and efficiency